Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform
-
Grayscale Dogecoin Trust ETF (Ticker: GDOG) Begins Trading on NYSE Arca as First Dogecoin ETP in the U.S.
-
HOUSTON AMERICAN ENERGY CORP. ANNOUNCES COMPLETION OF $8 MILLION REGISTERED DIRECT OFFERING TO INSTITUTIONAL INVESTORS
-
Lantheus to Present Florbetaben F 18 Data at CTAD 2025
-
Biotech Valuations Rise as New Clinical Platforms Show Progress
-
Strong Earnings Highlight Growing Investor Confidence in Hospitality Automation
-
Genetec predicts top physical security trends for 2026
-
CytoDyn to Present Prolonged Survival Data on Leronlimab in Metastatic Triple-Negative Breast Cancer at the San Antonio Breast Cancer Symposium
-
Solar Drone Executive Travels to Greece for Technical Discussions on Wildfire-Mitigation and Grid-Maintenance Drone Solutions
-
Form 8.3 - Avadel Pharmaceuticals plc
-
BitMEX Turns 11 - The Exchange that Taught Crypto How to Trade
-
Biodexa Activates First European Site for Registrational Phase 3 Serenta Trial in FAP
-
Attention Long-Term Shareholders of Fortrea Holdings, Inc. (NASDAQ: FTRE); enCore Energy Corp. (NASDAQ: EU); Humana Inc. (NYSE: HUM); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office I
-
Ramsey Theory Group CEO Dan Herbatschek Identifies the Three Most Significant Cybersecurity Threats for Businesses Coming in December 2025
-
Texas Border Agency Selects New Non-Lethal Response Subscription to Strengthen Officer and Community Safety
-
DIGITAL ALLY, INC. SUBSIDIARY KUSTOM ENTERTAINMENT UNVEILS 2026 COUNTRY STAMPEDE MUSIC FESTIVAL LINEUP
-
BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality
-
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
-
Alpha Modus Files Coordinated Patent Enforcement Actions Against V-Count and Stratacache, Advancing the Standardization of In-Store AI Infrastructure
-
Form 8.3 - IDOX plc - Octopus Investments
-
Canacol Energy Filed for Relief Under Chapter 15 of the U.S. Bankruptcy Code
-
Nanox.AI Bone Solutions, Advanced AI-Powered Software for Spine Assessment, Recommended by NICE for Early Value Assessment in UK National Health Service hospitals
-
Bridger Aerospace Secures Purchase Agreement for Two Spanish Super Scoopers, Bolstering Aerial Firefighting Power and Paving the Way for 2026 Expansion
-
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
-
Fancamp Appoints Jasper Bertisen to its Board of Directors Further to the Announcement of Strategic Reorganization
-
SunPower Reports Inducement Grants in Connection with Ambia Acquisition
-
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
-
Premier Aviation Corporation Hosts Full Tour for Rocco Mediate, Featuring Live Broadcast of The Rocco Hour
-
Condor’s First Horizontal Well in Uzbekistan Reaches TD While Two New Zone Workovers in an Adjacent Field Increase Daily Production to Approximately 12,000 boepd
-
Axalta Wins 2025 R&D 100 Award for Groundbreaking Fast Cure, Low Energy Collision Repair Paint System
-
Neuphoria Therapeutics Inc. Sends Letter to Stockholders
-
Monster Beverage Announces Webcast Details for Investor Meeting December 2, 2025; Company Announces Participation in Morgan Stanley Global Consumer & Retail Conference
-
Akebia Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
-
Office Care Inc. Expands Commercial Cleaning Services from Laurel Headquarters to Belcamp and Manassas
-
Liberty Defense Partners with Noble IQ to Provide Installation, Training, and Service for HEXWAVE™ Deployments
-
Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
-
HealthLynked Engages NE Holdings, LLC to Lead Strategic Advisory Services for Nasdaq Listing
-
LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME’s America’s Growth Leaders of 2026
-
Kaltura Recognized in Frost & Sullivan’s 2025 Global Enterprise Video Platform Market Report
-
LB Pharmaceuticals Announces Presentation at the Piper Sandler 37th Annual Healthcare Conference
-
Cidara Therapeutics Reaches Target Enrollment of Phase 3 ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations
-
NANO Nuclear Announces 1 GW Feasibility Study with BaRupOn LLC., a Technology-Driven American Manufacturing Company
-
LINK FOREX presents an innovative “investment as a side hustle” model to redefine global financial equity
-
GDEV announces results for the third quarter and first nine months of 2025
-
Launch of the Chessnut Evo: The Electronic Chessboard of the Future
-
Inno Holdings Inc. Announces Strategic Cooperation with Megabyte Solutions on Web3 Technology Application in B2B Marketplace Platform
-
American Rebel Holdings, Inc. (NASDAQ: AREB) Receives Nasdaq Panel Determination Confirming Compliance with Minimum Stockholders’ Equity Requirement
-
Atico Reports Multiple High-Grade Intercepts up to 8.70m of 11.44% Cu, 14.65 g/t Au and 6.16m of 13.32% Cu, 2.79 g/t Au and Continues to Extend the Ore Body at El Roble Mine in Colombia
-
SunPower Closes $37.5M Ambia Solar Acquisition
-
Chemomab to Participate in Oppenheimer’s Movers in Rare Disease Summit
